Drug Treatment of Dyspareunia

Intrarosa

Payments companies reported to CMS as associated with Intrarosa. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$274Kassociated payments (2023-2025)
6,757clinicians with associated payments
1company reporting

By year

2023 $34K
2024 $109K
2025 $131K

Payments reported as associated with Intrarosa, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Obstetrics & Gynecology $150K
Family $22K
Women'S Health (Nurse Practitioner) $22K
Gynecology $11K
Obstetrics & Gynecology (Nurse Practitioner) $10K
Physician Assistant $9,071

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Intrarosa

These are the largest totals companies reported as associated with Intrarosa. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Cheryl Potter Rockwall, TX Obstetrics & Gynecology $340.98
Julia Gillean Rockwall, TX Obstetrics & Gynecology $327.97
Amy Hantes Rockwall, TX Obstetrics & Gynecology (Nurse Practitioner) $315.27
Melissa Bailey Frisco, TX Obstetrics & Gynecology $302.93
Ladawn Cantu Rockwall, TX Women'S Health (Nurse Practitioner) $280.84
Tatiana Vu Molaschi Myrtle Beach, SC Obstetrics & Gynecology $272.75
Ruth Whiddon Grapevine, TX Women'S Health (Nurse Practitioner) $266.88
Mia Cowan Birmingham, AL Obstetrics & Gynecology $261.29
Arden Moulin Grapevine, TX Women'S Health (Nurse Practitioner) $257.11
Cheryl Millender Rowlett, TX Obstetrics & Gynecology (Nurse Practitioner) $244.72

Prescribed Intrarosa?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.